ASSESSMENTS

Pharmaceutical Trade Remains Resilient in the Face of COVID-19

Greg Priddy

Director, Global Energy and Middle East, Stratfor

Apr 8, 2020 | 10:00 GMT

A photo of pill packets. The COVID-19 pandemic has raised serious concerns about the extremely high concentration of global pharmaceutical supply chains sourced from China and India.

(Shutterfly/Nenov Brothers Images)

The United States and many other countries are heavily dependent on supplies of pharmaceuticals and precursor chemicals from China and India. Widespread shortages resulting from the COVID-19 outbreak remain unlikely. Legislative proposals in the United States to force companies to "reshore" supply chains will likely falter on the increase in costs and regulatory hurdles. ...

Keep Reading

Proceed to sign up

Already have an account?